A placebo-controlled, crossover trial to investigate the efficacy of tiotropium bromide or placebo added to usual care in stable symptomatic post-hematopoietic stem cell transplantation (HSCT) bronchiolitis obliterans syndrome (BOS).
Naeemeh DiniAmin Pastaki KhoshbinRasoul AliannejadHooman BakhshandehKatayoun NajafizadehMahshid MehdizadehShahideh AminiPublished in: Trials (2024)
Iranian Registry of Clinical Trial (IRCT) IRCT20200415047080N3. Registered on 2022-07-12, 1401/04/21.